Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial

Overview of attention for article published in Research and Reports in Urology, July 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS OF REDUCING RISK OF PROSTATE CANCER PROGRESSION

Application WO-2022181818-A1

World Intellectual Property Organisation (WIPO)